Key facts
- GV 2017, L.P. filed SCHEDULE 13G/A for VERVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (VERV).
- Disclosed ownership: 0%.
- Date of event: 25 Jul 2025.
GV 2017, L.P. - 25 Jul 2025 SCHEDULE 13G/A Report for VERVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (VERV)
- Filing manager
- GV 2017, L.P.
- Reporting owner
- GV 2017, L.P.
- Symbol
- VERV
- Disclosed shares
- 0 shares
- Ownership percentage
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 28 Jul 2025, 17:21:44 UTC
- Event date
- 25 Jul 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
GV 2017, L.P. disclosed 0% ownership in VERVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (VERV) on 25 Jul 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Jul 2025, 17:21.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (13)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| GV 2017, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2017 GP, L.L.C., the General Partner of GV 2017 GP, L.P., its General Partner | |
| GV 2017 GP, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2017 GP, L.L.C., its General Partner | |
| GV 2017 GP, L.L.C. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| GV 2019, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2019 GP, L.L.C., the General Partner of GV 2019 GP, L.P., its General Partner | |
| GV 2019 GP, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2019 GP, L.L.C., its General Partner | |
| GV 2019 GP, L.L.C. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| GV 2023, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2023 GP, L.L.C., the General Partner of GV 2023 GP, L.P., its General Partner | |
| GV 2023 GP, L.P. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel of GV 2023 GP, L.L.C., its General Partner | |
| GV 2023 GP, L.L.C. | 0% | 0 | 0 | 0 | /s/ Inga Goldbard | Inga Goldbard/General Counsel | |
| Alphabet Holdings LLC | 0% | 0 | 0 | 0 | /s/ Kathryn W. Hall | Kathryn W. Hall/Secretary | |
| Verily Life Sciences LLC | 0% | 0 | 0 | 0 | /s/ Utpal Koppikar | Utpal Koppikar/Finance Director | |
| XXVI Holdings Inc. | 0% | 0 | 0 | 0 | /s/ Kathryn W. Hall | Kathryn W. Hall/Assistant Secretary | |
| Alphabet Inc. | 0% | 0 | 0 | 0 | /s/ Kathryn W. Hall | Kathryn W. Hall/Assistant Secretary |
CIK / CUSIP context first